MicroRNA super-resolution imaging in blood for Alzheimer’s disease
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We propose a novel blood biomarker detection method thatuses miRNA super-resolution imaging to enable the early diagnosisof Alzheimer’s disease (AD). Here, we report a singlemoleculedetection method for visualizing disease-specificmiRNA in tissue from an AD mice model, and peripheral bloodmononuclear cells (PBMCs) from AD patients. Using optimizedMagnified Analysis of Proteome (MAPs), we confirmed that fivemiRNAs contribute to neurodegenerative disease in the brainhippocampi of 5XFAD and wild-type mice. We also assessedPBMCs isolated from the whole blood of AD patients and ahealthy control group, and subsequently analyzed those samplesusing miRNA super-resolution imaging. We detected moremiR-200a-3p expression in the cornu ammonis 1 and dentategyrus regions of 3 month-old 5XFAD mice than in wild-typemice. Additionally, miRNA super-resolution imaging of bloodprovides AD diagnosis platform for studying miRNA regulationinside cells at the single molecule level. Our results present apotential liquid biopsy method that could improve the diagnosisof early stage AD and other diseases.
Abstract
We propose a novel blood biomarker detection method thatuses miRNA super-resolution imaging to enable the early diagnosisof Alzheimer’s disease (AD). Here, we report a singlemoleculedetection method for visualizing disease-specificmiRNA in tissue from an AD mice model, and peripheral bloodmononuclear cells (PBMCs) from AD patients. Using optimizedMagnified Analysis of Proteome (MAPs), we confirmed that fivemiRNAs contribute to neurodegenerative disease in the brainhippocampi of 5XFAD and wild-type mice. We also assessedPBMCs isolated from the whole blood of AD patients and ahealthy control group, and subsequently analyzed those samplesusing miRNA super-resolution imaging. We detected moremiR-200a-3p expression in the cornu ammonis 1 and dentategyrus regions of 3 month-old 5XFAD mice than in wild-typemice. Additionally, miRNA super-resolution imaging of bloodprovides AD diagnosis platform for studying miRNA regulationinside cells at the single molecule level. Our results present apotential liquid biopsy method that could improve the diagnosisof early stage AD and other diseases.
참고문헌 (32)
- Jinny Claire Lee, "Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers", Experimental and Molecular Medicine, 51, pp.1~10 (2019), 생화학분자생물학회[DOI]
- Karssemeijer EGA, "Positive effects of combined cognitive and physical exercise training on cognitive function in older adults with mild cognitive impairment or dementia : a meta-analysis", Ageing Res Rev, 40, pp.75~83 (2017)
- Frisoni GB, "The clinical use of structural MRI in Alzheimer disease", Nat Rev Neurol, 6, pp.67~77 (2010)
- Ledig C, "Structural brain imaging in Alzheimer’s disease and mild cognitive impairment : biomarker analysis and shared morphometry database", Sci Rep, 8, pp.11258~ (2018)
- Folstein MF, "Minimental state", J Psychiatr Res, 12, pp.189~198 (1975)
- Chandra A, "Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer’s disease and mild cognitive impairment", Hum Brain Mapp, 40, pp.5424~5442 (2019)
- Ausó E, "Biomarkers for Alzheimer’s disease early diagnosis", J Pers Med, 10, pp.114~ (2020)
- Yáñez-Mó M, "Biological properties of extracellular vesicles and their physiological functions", J Extracell Vesicles, 4, pp.27066~ (2015)
- Liew CC, "The peripheral blood transcriptome dynamically reflects system wide biology : a potential diagnostic tool", J Lab Clin Med, 147, pp.126~132 (2006)
- Brouard S, "Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance", Proc Natl Acad Sci U S A, 104, pp.15448~15453 (2007)
- O’Brien J, "Overview of microRNA biogenesis, mechanisms of actions, and circulation", Front Endocrinol, 9, pp.402~ (2018)
- Schipper HM, "MicroRNA expression in Alzheimer blood mononuclear cells", Gene Regul Syst Bio, 1, pp.263~274 (2007)
- Banfi S, "Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson’s disease", PLoS One, 6, pp.e25443~ (2011)
- Leidinger P, "A blood based 12-miRNA signature of Alzheimer disease patients", Genome Biol, 14, pp.R78~ (2013)
- Ku T, "Multiplexed and scalable super-resolution imaging of three-dimensional protein localization in size-adjustable tissues", Nature Biotechnol, 34, pp.973~981 (2016)
- Woo J, "A modified magnified analysis of proteome(MAP)method for super-resolution cell imaging that retains fluorescence", Sci Rep, 10, pp.4186~ (2020)
- Lee M, "A novel paper MAP method for rapid high resolution histological analysis", Sci Rep, 11, pp.23340~ (2021)
- Zhao J, "MicroRNA-7 : expression and function in brain physiological and pathological processes", Cell Biosci, 10, pp.77~ (2020)
- Jin W, "Overexpression of miR-671-5p indicates a poor prognosis in colon cancer and accelerates proliferation, migration, and invasion of colon cancer cells", OncoTargets Ther, 12, pp.6865~6873 (2019)
- Azari H, "The expanding role of CDR1-AS in the regulation and development of cancer and human diseases", J Cell Physiol, 236, pp.771~790 (2020)
- De Strooper B, "The cellular phase of Alzheimer’s disease", Cell, 164, pp.603~615 (2016)
- Murphy MP, "Alzheimer’s disease and the amyloid-β peptide", J Alzheimer’s Dis, 19, pp.311~323 (2010)
- Ulep MG, "Alzheimer disease", Nurse Pract, 14, pp.129~135 (2018)
- Thalhauser CJ, "Alzheimer’s disease : rapid and slow progression", J R Soc Interface, 9, pp.119~126 (2011)
- Zhou Y, "Comprehensive analysis of the lncRNA-associated ceRNA network identifies neuroinflammation biomarkers for Alzheimer’s disease", Mol Omics, 15, pp.459~469 (2019)
- Hooten NN, "Agerelated changes in microRNA levels in serum", Aging, 5, pp.725~740 (2013)
- Humpel C, "Cerebrospinal fluid and blood biomarkers in Alzheimer’s disease", World J Psychiatry, 1, pp.8~18 (2011)
- O’Bryant SE, "Blood-based biomarkers in Alzheimer disease : current state of the science and a novel collaborative paradigm for advancing from discovery to clinic", Alzheimers Dement, 13, pp.45~58 (2016)
- Nagaraj S, "Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer’s disease patients from non-demented subjects", Oncotarget, 8, pp.16122~16143 (2017)
- Lau P, "Alteration of the microRNA network during the progression of Alzheimer’s disease", EMBO Mol Med, 5, pp.1613~1634 (2013)
- Zhang Q, "miR-200a-3p promotes b-Amyloid-induced neuronal apoptosis through down-regulation of SIRT1 in Alzheimer’s disease", J Biosci, 42, pp.397~404 (2017)
- Herskovits AZ, "SIRT1 in neurodevelopment and brain senescence", Neuron, 5, pp.471~483 (2014)